Castle Biosciences OverviewCastle Biosciences EBIT
EBIT (Earnings Before Interest and Taxes) analysis for CSTL.
Quarterly EBIT
-$14.41M
As of Mar 31, 2026
Annual EBIT (TTM)
-$31.57M
↓ 317.33% YoY
Trailing 12 months ending Mar 31, 2026
Castle Biosciences OverviewEBIT (Earnings Before Interest and Taxes) analysis for CSTL.
As of Mar 31, 2026
Trailing 12 months ending Mar 31, 2026